Functional Technologies Corp  

(Public, CVE:FEB)   Watch this stock  
Find more results for FEB
Jun 11 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.16
Open     -
Vol / Avg. 0.00/0.00
Mkt cap 306,852.00
P/E     -
Div/yield     -
EPS -0.16
Shares     -
Beta 1.37
Inst. own     -

Key stats and ratios

Q1 (Feb '13) 2012
Net profit margin 79.38% -7178.16%
Operating margin -608.97% -7178.15%
EBITD margin - -4573.04%
Return on average assets 2.93% -184.01%
Return on average equity - -500.77%
CDP Score - -


Suite 410, University of British Colmbia 2389 Heath Sciences Mall

Website links


Functional Technologies Corp. (Functional Technologies) is a development-stage and a technology company focused on developing and commercializing yeast and algae-based products for the global food, beverage and healthcare markets. The Company�s focus is on developing functional foods and biological health products. Functional Technologies� technologies include yeasts that prevent and reduce the formation of the foul smelling hydrogen sulphide (H2S) and the carcinogens acrylamide and ethyl carbamate (known as urethane), by-products of food and beverage processing. The Company has developed these yeasts for winemaking and is selling to, and trialing with, commercial wineries in North America, South America and Europe. The Company product and pipeline includes Acrylamide, H2S and yeast. It maintains equipped research labs in Prince Edward Island. Its subsidaries include Phyterra Bio Inc., Phyterra Yeast Inc., Phyterra Yeast, Inc., Maritime Pulse Drying Inc. and Phyterra Europe GmbH.

Officers and directors

Christopher Morris Interim Chief Executive Officer
John Husnik Chief Technology and Innovations Officer
Richard L. Sherman J.D. Independent Non-Executive Chairman of the Board
Age: 67
Ron Paton Director
David E. Allard Independent Director
Fabio M. Banducci Independent Director